knowledge -WSS

knowledge

author：entertainment 2025-09-03 03:25:31 - browse：558

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How to make AI work for medicine

focus

WSS

Stanford president faces new allegations over 1999 paper

What do new weight loss drugs mean for bariatric surgery?

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

NYU Langone launches private ChatGPT for its health care data

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

knowledge

knowledge

explore

Peter Hotez and the public health issue of online harassment

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Tori Bowie and the unacceptable rates of Black maternal death

Winners, losers from Medicare’s list of drugs subject to price talks

United colonoscopy coverage change 'may cost lives,' doctors say

Complete sequence of Y chromosome published for first time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospitals struggle to profit from CAR

In age of alternative facts, a scholarly course on calling out crap

2024 GOP presidential candidates spar over abortion in debate

focus

Ending racial health disparities hinges on penalties, political will

Awakening the world to the whoosh: A patient's crusade

Hospitals struggle to profit from CAR

Apellis safety probe of eye disease drug centers on injection needle

How to make Best Hospitals ratings actually useful for patients

Psilocybin's anti

knowledge

explore

focus

focus